Yutiq
Payments companies reported to CMS as associated with Yutiq. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Yutiq, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Yutiq
These are the largest totals companies reported as associated with Yutiq. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Lisa Faia | Royal Oak, MI | Retina Specialist | $103,317.88 |
| Mark Dacey | Denver, CO | Ophthalmology | $88,026.74 |
| Daniel Kiernan | Sarasota, FL | Ophthalmology | $49,811.03 |
| Arjun Sood | Blue Ash, OH | Ophthalmology | $46,348.68 |
| Jorge Fortun | Palm Beach Gardens, FL | Ophthalmology | $39,306.31 |
| Donald Mazzulla | New Orleans, LA | Retina Specialist | $34,720.35 |
| Dilsher Dhoot | Santa Barbara, CA | Retina Specialist | $30,596.71 |
| Stephen Anesi | Waltham, MA | Ophthalmology | $28,540.81 |
| Michael Singer | San Antonio, TX | Ophthalmology | $25,419.57 |
| Peter Chang | Waltham, MA | Ophthalmology | $24,825.04 |
Prescribed Yutiq?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.